Downregulation of ACTBL2 In Vitro Decreases Viability, Proliferation and Migration of UWB1.289 Cells, Indicating Its Functional Role in Serous Ovarian Cancer. Here, ACTBL2 is linked to ovarian serous adenocarcinoma.